Which Patients May Be Administered Tissue Plasminogen Activator Safely?
Which Patients May Be Administered Tissue Plasminogen Activator Safely? Tissue plasminogen activator (tPA) is an intravenous medicine given for ischemic stroke – a stroke caused by a blood clot – that can dissolve the stroke-causing clot. Studies show that people who receive tPA within 3 hours – up to 4.5 hours in some patients –